Global Dementia Drugs Market Professional Survey Report 2019

Published on: Sep 2019 | From USD 3500 | Number Of Pages: 114 | Life Sciences


The global Dementia Drugs market was valued at 13900 million US$ in 2018 and will reach 26500 million US$ by the end of 2025, growing at a CAGR of 8.4% during 2019-2025.
This report focuses on Dementia Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Dementia Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Dementia Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Dementia Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Eisai, Inc
Janssen Pharmaceuticals, Inc
Biogen Pharmaceuticals
Forest Laboratories, Inc
Eli Lilly and Company
Novartis AG
Sanofi S.A
AstraZeneca GmbH
F. Hoffmann-La Roche
Merck & Co., Inc
Valeant Pharmaceutical International
Pfizer Inc
Teva Pharmaceuticals Industries

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
MAO Inhibitors
Cholinesterase Inhibitors
Glutamate Inhibitors

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Others
Table of Contents

Executive Summary
1 Industry Overview of Dementia Drugs
1.1 Definition of Dementia Drugs
1.2 Dementia Drugs Segment by Type
1.2.1 Global Dementia Drugs Production Growth Rate Comparison by Types (2014-2025)
1.2.2 MAO Inhibitors
1.2.3 Cholinesterase Inhibitors
1.2.4 Glutamate Inhibitors
1.3 Dementia Drugs Segment by Applications
1.3.1 Global Dementia Drugs Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Others
1.4 Global Dementia Drugs Overall Market
1.4.1 Global Dementia Drugs Revenue (2014-2025)
1.4.2 Global Dementia Drugs Production (2014-2025)
1.4.3 North America Dementia Drugs Status and Prospect (2014-2025)
1.4.4 Europe Dementia Drugs Status and Prospect (2014-2025)
1.4.5 China Dementia Drugs Status and Prospect (2014-2025)
1.4.6 Japan Dementia Drugs Status and Prospect (2014-2025)
1.4.7 Southeast Asia Dementia Drugs Status and Prospect (2014-2025)
1.4.8 India Dementia Drugs Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Dementia Drugs
2.3 Manufacturing Process Analysis of Dementia Drugs
2.4 Industry Chain Structure of Dementia Drugs

3 Development and Manufacturing Plants Analysis of Dementia Drugs
3.1 Capacity and Commercial Production Date
3.2 Global Dementia Drugs Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Dementia Drugs
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Dementia Drugs Production and Capacity Analysis
4.2 Dementia Drugs Revenue Analysis
4.3 Dementia Drugs Price Analysis
4.4 Market Concentration Degree

5 Dementia Drugs Regional Market Analysis
5.1 Dementia Drugs Production by Regions
5.1.1 Global Dementia Drugs Production by Regions
5.1.2 Global Dementia Drugs Revenue by Regions
5.2 Dementia Drugs Consumption by Regions
5.3 North America Dementia Drugs Market Analysis
5.3.1 North America Dementia Drugs Production
5.3.2 North America Dementia Drugs Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Dementia Drugs Import and Export
5.4 Europe Dementia Drugs Market Analysis
5.4.1 Europe Dementia Drugs Production
5.4.2 Europe Dementia Drugs Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Dementia Drugs Import and Export
5.5 China Dementia Drugs Market Analysis
5.5.1 China Dementia Drugs Production
5.5.2 China Dementia Drugs Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Dementia Drugs Import and Export
5.6 Japan Dementia Drugs Market Analysis
5.6.1 Japan Dementia Drugs Production
5.6.2 Japan Dementia Drugs Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Dementia Drugs Import and Export
5.7 Southeast Asia Dementia Drugs Market Analysis
5.7.1 Southeast Asia Dementia Drugs Production
5.7.2 Southeast Asia Dementia Drugs Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Dementia Drugs Import and Export
5.8 India Dementia Drugs Market Analysis
5.8.1 India Dementia Drugs Production
5.8.2 India Dementia Drugs Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Dementia Drugs Import and Export

6 Dementia Drugs Segment Market Analysis (by Type)
6.1 Global Dementia Drugs Production by Type
6.2 Global Dementia Drugs Revenue by Type
6.3 Dementia Drugs Price by Type

7 Dementia Drugs Segment Market Analysis (by Application)
7.1 Global Dementia Drugs Consumption by Application
7.2 Global Dementia Drugs Consumption Market Share by Application (2014-2019)

8 Dementia Drugs Major Manufacturers Analysis
8.1 Eisai, Inc
8.1.1 Eisai, Inc Dementia Drugs Production Sites and Area Served
8.1.2 Eisai, Inc Product Introduction, Application and Specification
8.1.3 Eisai, Inc Dementia Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Janssen Pharmaceuticals, Inc
8.2.1 Janssen Pharmaceuticals, Inc Dementia Drugs Production Sites and Area Served
8.2.2 Janssen Pharmaceuticals, Inc Product Introduction, Application and Specification
8.2.3 Janssen Pharmaceuticals, Inc Dementia Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Biogen Pharmaceuticals
8.3.1 Biogen Pharmaceuticals Dementia Drugs Production Sites and Area Served
8.3.2 Biogen Pharmaceuticals Product Introduction, Application and Specification
8.3.3 Biogen Pharmaceuticals Dementia Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Forest Laboratories, Inc
8.4.1 Forest Laboratories, Inc Dementia Drugs Production Sites and Area Served
8.4.2 Forest Laboratories, Inc Product Introduction, Application and Specification
8.4.3 Forest Laboratories, Inc Dementia Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Eli Lilly and Company
8.5.1 Eli Lilly and Company Dementia Drugs Production Sites and Area Served
8.5.2 Eli Lilly and Company Product Introduction, Application and Specification
8.5.3 Eli Lilly and Company Dementia Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Novartis AG
8.6.1 Novartis AG Dementia Drugs Production Sites and Area Served
8.6.2 Novartis AG Product Introduction, Application and Specification
8.6.3 Novartis AG Dementia Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Sanofi S.A
8.7.1 Sanofi S.A Dementia Drugs Production Sites and Area Served
8.7.2 Sanofi S.A Product Introduction, Application and Specification
8.7.3 Sanofi S.A Dementia Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 AstraZeneca GmbH
8.8.1 AstraZeneca GmbH Dementia Drugs Production Sites and Area Served
8.8.2 AstraZeneca GmbH Product Introduction, Application and Specification
8.8.3 AstraZeneca GmbH Dementia Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 F. Hoffmann-La Roche
8.9.1 F. Hoffmann-La Roche Dementia Drugs Production Sites and Area Served
8.9.2 F. Hoffmann-La Roche Product Introduction, Application and Specification
8.9.3 F. Hoffmann-La Roche Dementia Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Merck & Co., Inc
8.10.1 Merck & Co., Inc Dementia Drugs Production Sites and Area Served
8.10.2 Merck & Co., Inc Product Introduction, Application and Specification
8.10.3 Merck & Co., Inc Dementia Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Valeant Pharmaceutical International
8.12 Pfizer Inc
8.13 Teva Pharmaceuticals Industries

9 Development Trend of Analysis of Dementia Drugs Market
9.1 Global Dementia Drugs Market Trend Analysis
9.1.1 Global Dementia Drugs Market Size (Volume and Value) Forecast 2019-2025
9.2 Dementia Drugs Regional Market Trend
9.2.1 North America Dementia Drugs Forecast 2019-2025
9.2.2 Europe Dementia Drugs Forecast 2019-2025
9.2.3 China Dementia Drugs Forecast 2019-2025
9.2.4 Japan Dementia Drugs Forecast 2019-2025
9.2.5 Southeast Asia Dementia Drugs Forecast 2019-2025
9.2.6 India Dementia Drugs Forecast 2019-2025
9.3 Dementia Drugs Market Trend (Product Type)
9.4 Dementia Drugs Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Dementia Drugs Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
List of Tables and Figures
Figure Picture of Dementia Drugs
Table Global Dementia Drugs Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Dementia Drugs Production Market Share by Types in 2018
Figure MAO Inhibitors Product Picture
Figure Cholinesterase Inhibitors Product Picture
Figure Glutamate Inhibitors Product Picture
Table Global Dementia Drugs Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Dementia Drugs Consumption Market Share by Applications in 2018
Figure Hospital Pharmacies
Figure Retail Pharmacies
Figure Others
Figure Global Dementia Drugs Revenue (Million USD) (2014-2025)
Figure Global Dementia Drugs Production (K Units) (2014-2025)
Figure North America Dementia Drugs Market Size (Million USD) (2014-2025)
Figure Europe Dementia Drugs Market Size (Million USD) (2014-2025)
Figure China Dementia Drugs Market Size (Million USD) (2014-2025)
Figure Japan Dementia Drugs Market Size (Million USD) (2014-2025)
Figure Southeast Asia Dementia Drugs Market Size (Million USD) (2014-2025)
Figure India Dementia Drugs Market Size (Million USD) (2014-2025)
Table Dementia Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Dementia Drugs in 2018
Figure Manufacturing Process Analysis of Dementia Drugs
Figure Industry Chain Structure of Dementia Drugs
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Dementia Drugs Manufacturing Plants Distribution
Table Dementia Drugs Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Dementia Drugs Capacity (K Units) of Major Manufacturers (2014-2019)
Table Dementia Drugs Production (K Units) of Major Manufacturers (2014-2019)
Table Dementia Drugs Production Market Share of Major Manufacturers (2014-2019)
Figure Dementia Drugs Production Share by Manufacturers in 2018
Table Dementia Drugs Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Dementia Drugs Revenue Market Share of Major Manufacturers (2014-2019)
Figure Dementia Drugs Revenue Share by Manufacturers in 2018
Table Dementia Drugs Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Dementia Drugs Production by Regions 2014-2019 (K Units)
Table Global Dementia Drugs Production Market Share by Regions 2014-2019
Figure Global Dementia Drugs Production Market Share by Regions in 2018
Table Global Dementia Drugs Revenue by Regions 2014-2019 (Million USD)
Table Global Dementia Drugs Revenue Market Share by Regions 2014-2019
Figure Global Dementia Drugs Revenue Market Share by Regions in 2018
Table Global Dementia Drugs Consumption by Regions 2014-2019 (K Units)
Table Global Dementia Drugs Consumption Market Share by Regions 2014-2019
Figure North America Dementia Drugs Production Growth Rate 2014-2019 (K Units)
Figure North America Dementia Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table North America Dementia Drugs Production, Consumption Import and Export (K Units)
Figure Europe Dementia Drugs Production Growth Rate 2014-2019 (K Units)
Figure Europe Dementia Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Dementia Drugs Production, Consumption Import and Export (K Units)
Figure China Dementia Drugs Production Growth Rate 2014-2019 (K Units)
Figure China Dementia Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table China Dementia Drugs Production, Consumption Import and Export (K Units)
Figure Japan Dementia Drugs Production Growth Rate 2014-2019 (K Units)
Figure Japan Dementia Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Dementia Drugs Production, Consumption Import and Export (K Units)
Figure Southeast Asia Dementia Drugs Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Dementia Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Dementia Drugs Production, Consumption Import and Export (K Units)
Figure India Dementia Drugs Production Growth Rate 2014-2019 (K Units)
Figure India Dementia Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table India Dementia Drugs Production, Consumption Import and Export (K Units)
Figure Global Consumption Dementia Drugs Market Share by Application (2014-2019)
Figure Global Value (Consumption) Dementia Drugs Market Share by Application (2014-2019)
Table Eisai, Inc Dementia Drugs Production Sites and Area Served
Table Eisai, Inc Dementia Drugs Product Introduction, Application and Specification
Table Eisai, Inc Dementia Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Eisai, Inc Dementia Drugs Production Growth Rate (2014-2019)
Table Eisai, Inc Dementia Drugs Production Market Share (2014-2019)
Figure Eisai, Inc Dementia Drugs Revenue Market Share (2014-2019)
Table Eisai, Inc Dementia Drugs Main Business and Markets Served
Table Janssen Pharmaceuticals, Inc Dementia Drugs Production Sites and Area Served
Table Janssen Pharmaceuticals, Inc Dementia Drugs Product Introduction, Application and Specification
Table Janssen Pharmaceuticals, Inc Dementia Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Janssen Pharmaceuticals, Inc Dementia Drugs Production Growth Rate (2014-2019)
Table Janssen Pharmaceuticals, Inc Dementia Drugs Production Market Share (2014-2019)
Figure Janssen Pharmaceuticals, Inc Dementia Drugs Revenue Market Share (2014-2019)
Table Janssen Pharmaceuticals, Inc Dementia Drugs Main Business and Markets Served
Table Biogen Pharmaceuticals Dementia Drugs Production Sites and Area Served
Table Biogen Pharmaceuticals Dementia Drugs Product Introduction, Application and Specification
Table Biogen Pharmaceuticals Dementia Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Biogen Pharmaceuticals Dementia Drugs Production Growth Rate (2014-2019)
Table Biogen Pharmaceuticals Dementia Drugs Production Market Share (2014-2019)
Figure Biogen Pharmaceuticals Dementia Drugs Revenue Market Share (2014-2019)
Table Biogen Pharmaceuticals Dementia Drugs Main Business and Markets Served
Table Forest Laboratories, Inc Dementia Drugs Production Sites and Area Served
Table Forest Laboratories, Inc Dementia Drugs Product Introduction, Application and Specification
Table Forest Laboratories, Inc Dementia Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Forest Laboratories, Inc Dementia Drugs Production Growth Rate (2014-2019)
Table Forest Laboratories, Inc Dementia Drugs Production Market Share (2014-2019)
Figure Forest Laboratories, Inc Dementia Drugs Revenue Market Share (2014-2019)
Table Forest Laboratories, Inc Dementia Drugs Main Business and Markets Served
Table Eli Lilly and Company Dementia Drugs Production Sites and Area Served
Table Eli Lilly and Company Dementia Drugs Product Introduction, Application and Specification
Table Eli Lilly and Company Dementia Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Eli Lilly and Company Dementia Drugs Production Growth Rate (2014-2019)
Table Eli Lilly and Company Dementia Drugs Production Market Share (2014-2019)
Figure Eli Lilly and Company Dementia Drugs Revenue Market Share (2014-2019)
Table Eli Lilly and Company Dementia Drugs Main Business and Markets Served
Table Novartis AG Dementia Drugs Production Sites and Area Served
Table Novartis AG Dementia Drugs Product Introduction, Application and Specification
Table Novartis AG Dementia Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis AG Dementia Drugs Production Growth Rate (2014-2019)
Table Novartis AG Dementia Drugs Production Market Share (2014-2019)
Figure Novartis AG Dementia Drugs Revenue Market Share (2014-2019)
Table Novartis AG Dementia Drugs Main Business and Markets Served
Table Sanofi S.A Dementia Drugs Production Sites and Area Served
Table Sanofi S.A Dementia Drugs Product Introduction, Application and Specification
Table Sanofi S.A Dementia Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi S.A Dementia Drugs Production Growth Rate (2014-2019)
Table Sanofi S.A Dementia Drugs Production Market Share (2014-2019)
Figure Sanofi S.A Dementia Drugs Revenue Market Share (2014-2019)
Table Sanofi S.A Dementia Drugs Main Business and Markets Served
Table AstraZeneca GmbH Dementia Drugs Production Sites and Area Served
Table AstraZeneca GmbH Dementia Drugs Product Introduction, Application and Specification
Table AstraZeneca GmbH Dementia Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca GmbH Dementia Drugs Production Growth Rate (2014-2019)
Table AstraZeneca GmbH Dementia Drugs Production Market Share (2014-2019)
Figure AstraZeneca GmbH Dementia Drugs Revenue Market Share (2014-2019)
Table AstraZeneca GmbH Dementia Drugs Main Business and Markets Served
Table F. Hoffmann-La Roche Dementia Drugs Production Sites and Area Served
Table F. Hoffmann-La Roche Dementia Drugs Product Introduction, Application and Specification
Table F. Hoffmann-La Roche Dementia Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche Dementia Drugs Production Growth Rate (2014-2019)
Table F. Hoffmann-La Roche Dementia Drugs Production Market Share (2014-2019)
Figure F. Hoffmann-La Roche Dementia Drugs Revenue Market Share (2014-2019)
Table F. Hoffmann-La Roche Dementia Drugs Main Business and Markets Served
Table Merck & Co., Inc Dementia Drugs Production Sites and Area Served
Table Merck & Co., Inc Dementia Drugs Product Introduction, Application and Specification
Table Merck & Co., Inc Dementia Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck & Co., Inc Dementia Drugs Production Growth Rate (2014-2019)
Table Merck & Co., Inc Dementia Drugs Production Market Share (2014-2019)
Figure Merck & Co., Inc Dementia Drugs Revenue Market Share (2014-2019)
Table Merck & Co., Inc Dementia Drugs Main Business and Markets Served
Table Valeant Pharmaceutical International Dementia Drugs Production Sites and Area Served
Table Pfizer Inc Dementia Drugs Production Sites and Area Served
Table Teva Pharmaceuticals Industries Dementia Drugs Production Sites and Area Served
Figure Global Dementia Drugs Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Dementia Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Dementia Drugs Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Dementia Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Dementia Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Dementia Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Dementia Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Dementia Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Dementia Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Dementia Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Dementia Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Dementia Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Dementia Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Dementia Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Dementia Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Dementia Drugs by Type (2019-2025)
Table Global Consumption (K Units) of Dementia Drugs by Application (2019-2025)
Table Dementia Drugs Distributors List
Table Dementia Drugs Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
SECONDARY RESEARCH

Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH

Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING

The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION

The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION

After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.